Intervention in the prescribing of the combination of an angiotensin converting enzyme inhibitor and an angiotensin-II receptor blocker

被引：2
|
作者：
Portilla, Alfredo [1 ]
Torres, Daniel [1 ]
Enrique Machado-Duque, Manuel [2 ]
Enrique Machado-Alba, Jorge [2 ]
机构：
[1] Audifarma SA, Pereira, Colombia
[2] Univ Tecnol Pereira Audifarma SA, Grp Invest Farmacoepidemiol & Farmacovigilancia, Pereira, Colombia
来源：
ATENCION PRIMARIA | 2016年 / 48卷 / 04期
关键词：
RATIONALE; ARB;
D O I：
10.1016/j.aprim.2015.07.004
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：272 / 274
页数：3
相关论文
共 50 条
  • [1] Successful treatment of severe hypertension with the combination of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker
    Tanemoto, M
    Abe, T
    Obara, N
    Abe, M
    Satoh, F
    Ito, S
    HYPERTENSION RESEARCH, 2003, 26 (10) : 863 - 868
  • [2] Effects of combination therapy of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker
    Idrizi, A
    Gjata, M
    Barbullushi, M
    Koroshi, A
    Tase, M
    Sadiku, E
    Hoti, K
    JOURNAL OF HYPERTENSION, 2005, 23 : S398 - S398
  • [3] Combination therapy with an angiotensin converting enzyme inhibitor and an angiotensin-II receptor antagonist for refractory essential hypertension
    Bisognano, JD
    Horwitz, LD
    WESTERN JOURNAL OF MEDICINE, 1998, 168 (04): : 272 - 274
  • [4] Acute effect of angiotensin II receptor blocker and angiotensin converting enzyme inhibitor on baroreflex
    Shimizu, M
    Mochizuki, T
    Sasaoka, T
    Kurosawa, T
    Kurokawa, S
    Tsuyusaki, T
    Izumi, T
    JOURNAL OF HYPERTENSION, 2000, 18 : S232 - S232
  • [5] Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
    Lee, Hyun Woo
    Suh, Jae Kyung
    Jang, Eunjin
    Lee, Sang-Min
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (02): : 371 - 381
  • [6] Antiproteinuric effect of triple blockage with angiotensin-converting-enzyme inhibitor, angiotensin-II receptor blocker and spironolactone.
    Furumatsu, Y
    Shoji, T
    Tomida, K
    Mikami, S
    Kaneko, T
    Togawa, M
    Okada, N
    Tsubakihara, Y
    Imai, E
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 762A - 762A
  • [7] Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure
    Carson, PE
    AMERICAN HEART JOURNAL, 2000, 140 (03) : 361 - 366
  • [8] Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on ventricular defibrillation threshold
    Kamochi, Hideyuki
    Yamanouchi, Yoshio
    Saku, Keijiro
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2006, 29 (07): : 747 - 752
  • [9] Optimal dose of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker for renoprotection
    Hou, Fan Fan
    Zhou, Qiu Gen
    NEPHROLOGY, 2010, 15 : 57 - 60
  • [10] Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease. Results of COOPERATE
    Lyakishev, AA
    KARDIOLOGIYA, 2003, 43 (09) : 76 - 76
12345